BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amjadi MF, Adyniec RR, Gupta S, Bashar SJ, Mergaert AM, Braun KM, Moreno GK, O'Connor DH, Friedrich TC, Safdar N, McCoy SS, Shelef MA. Anti-membrane and anti-spike antibodies are long-lasting and together discriminate between past COVID-19 infection and vaccination. medRxiv 2021:2021. [PMID: 34790984 DOI: 10.1101/2021.11.02.21265750] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 McConnell D, Harte M, Walsh C, Murphy D, Nichol A, Barry M, Adams R. Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis. Sci Rep 2022;12:17561. [PMID: 36266486 DOI: 10.1038/s41598-022-22431-6] [Reference Citation Analysis]
2 Abbott S, Funk S. Estimating epidemiological quantities from repeated cross-sectional prevalence measurements.. [DOI: 10.1101/2022.03.29.22273101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]